Literature DB >> 33512465

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.

Moritz Fürstenau1, Anna Maria Fink1, Anke Schilhabel2, Jonathan Weiss1, Sandra Robrecht1, Robert Eckert3, Javier de la Serna4, Marta Crespo5,6, Marta Coscia7, Candida Vitale7, Sebastian Böttcher2,8, Gesche Weppner2, Matthias Ritgen2, Stephan Stilgenbauer9,10, Eugen Tausch9, Kirsten Fischer1, Michael Hallek1,11, Barbara Eichhorst1, Monika Brüggemann2, Carmen D Herling1.   

Abstract

Entities:  

Year:  2021        PMID： 33512465     DOI： 10.1182/blood.2020008609

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

Authors:  Ricardo D Parrondo; Zaid Abdel Rahman; Michael G Heckman; Mikolaj Wieczorek; Liuyan Jiang; Hassan B Alkhateeb; Mark R Litzow; Patricia Greipp; Taimur Sher; Leif Bergsagel; Rafael Fonseca; Vivek Roy; Angela Dispenzieri; Mohamed A Kharfan-Dabaja; Hemant S Murthy; Sikander Ailawadhi; James M Foran
Journal:  Blood Cancer J       Date:  2022-06-01       Impact factor: 9.812

Review 2.  Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

Authors:  Clare Sun; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2021-05-26       Impact factor: 2.861
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.